Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI.
@article{Huang2005BlockadeOB,
title={Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI.},
author={Bing S. Huang and Frans H H Leenen},
journal={American journal of physiology. Heart and circulatory physiology},
year={2005},
volume={288 5},
pages={
H2491-7
}
}In rats post-myocardial infarction (MI), sympathetic hyperactivity can be prevented by blockade of brain mineralocorticoid receptors (MR). Stimulatory responses to central infusion of aldosterone can be blocked by benzamil and therefore appear to be mediated via Na+ channels, presumably epithelial Na+ channels (ENaC), in the brain. To evaluate this concept of endogenous mineralocorticoids in Wistar rats post-MI, we examined effects of blockade of MR and Na+ channels in the brain. At 3 days…
61 Citations
Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
- Biology, MedicineCardiovascular research
- 2009
The data suggest that aldosterone produced locally in the brain acts as the main agonist of mineralocorticoid receptors in the CNS and contributes substantially to the progressive heart failure post MI.
Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction.
- Biology, MedicineCardiovascular research
- 2013
Results indicate that brain APA and Ang III appear to play a pivotal role in the sympathetic hyperactivity and LV dysfunction in rats post-MI and RB150 may be a potential candidate for central nervous system-targeted therapy post- MI.
Blockade of mineralocorticoid receptors improves salt-induced left-ventricular systolic dysfunction through attenuation of enhanced sympathetic drive in mice with pressure overload
- Biology, MedicineJournal of hypertension
- 2010
Findings indicate that activation of brain αENaC and AT1R through mineralocorticoid receptors contributes to the acquisition of Na sensitivity to induce sympathoexcitation and high salt intake accelerates sympathetic activation and LV systolic dysfunction in a pressure overload model.
Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats
- Biology, MedicineHypertension Research
- 2012
It is suggested that activation of MRs in the RVLM enhances sympathetic activity, thereby contributing to the neural mechanism of hypertension in the SHRSP.
Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade.
- Medicine, BiologyJournal of molecular and cellular cardiology
- 2007
Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory
- Biology, Medicine
- 2006
This study reveals a previously unrecognized effect of MR antagonism to minimize cytokine-induced central neural excitation in rats with HF, and results show no improvement in left ventricular function.
Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure
- Biology, MedicineCirculation research
- 2006
A previously unrecognized effect of MR antagonism is revealed to minimize cytokine-induced central neural excitation in rats with HF and reduce hypothalamic COX-2 expression and PVN neuronal activation.
Regulation of hypothalamic renin–angiotensin system and oxidative stress by aldosterone
- BiologyExperimental physiology
- 2011
Data indicate that aldosterone, via ‘ouabain’, increases in the PVN angiotensin‐converting enzyme, AT1R and oxidative stress, but decreases nNOS, and suggest that endogenous ald testosterone may cause the similar pattern of changes observed in salt‐sensitive hypertension and heart failure postmyocardial infarction.
Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
- Medicine, BiologyAmerican journal of hypertension
- 2015
Aldosterone contributes to autonomic dysfunction and intrarenal injury in 2K1C, these effects are mediated by the CNS.
Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride.
- Biology, MedicineAmerican journal of hypertension
- 2007
References
SHOWING 1-10 OF 50 REFERENCES
Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.
- Biology, PsychologyAmerican journal of physiology. Heart and circulatory physiology
- 1999
It is concluded that the chronic increase in sympathoexcitation, decrease in sympathoinhibition, and desensitized baroreflex function in CHF all appear to depend on the brain RAS, since this whole pattern of changes can be normalized by chronic central AT1-receptor blockade with losartan.
Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension.
- Biology, MedicineAmerican journal of physiology. Heart and circulatory physiology
- 2003
Findings indicate that in the brain, mineralocorticoids activate brain sodium channels, with small increases in CSF Na+ leading to increases in brain OLC, sympathetic outflow, and blood pressure.
Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure.
- Biology, PsychologyAmerican journal of physiology. Heart and circulatory physiology
- 2001
It is suggested that activation of MC receptors in the central nervous system plays a critical role in the altered volume regulation and augmented sympathetic drive that characterize clinical heart failure.
Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats.
- Biology, MedicineAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2003
Findings suggest that activation of MR in the central nervous system plays a critical role in regulating TNF-alpha release in heart failure rats, and some of the beneficial effect of blocking MR inHeart failure could be due at least in part to a reduction in TNF -alpha production.
Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake.
- Biology, MedicineHypertension
- 1998
The present data indicate that in Dahl S on high salt, both brain "ouabain" and angiotensin II contribute to decreased sympathoinhibition and increased sympathoexcitation, impairment of baroreflex, and therefore hypertension.
Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure.
- Biology, MedicineAmerican journal of physiology. Heart and circulatory physiology
- 2004
A critically important contribution of the brain renin-angiotensin system to the pathophysiology of congestive heart failure is confirmed.
Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure.
- Biology, MedicineCirculation research
- 1995
Whether brain OLA mediates sympathetic hyperactivity in CHF is determined and changes in peripheral and central OLA in two animal models of CHF are assessed and significant increases in both plasma and tissue OLA are identified.
Brain Sodium Channels Mediate Increases in Brain “Ouabain” and Blood Pressure in Dahl S Rats
- Biology, MedicineHypertension
- 2002
It is indicated that in Dahl S rats high salt intake only increases brain and not peripheral “ouabain” and that benzamil-blockable brain sodium channels mediate the increases in brain ‘ouabains’ and the subsequent hypertension.
The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.
- Biology, MedicineJournal of cardiac failure
- 1998
Neurohormonal antagonism in heart failure ; beneficial effects of vasopressin V and V receptor blockade and ACE inhibition 1 a 2 *
- Medicine, Biology
- 2002
In CHF, blockade of vasopressin V and V receptors was associated 1a 2 with increased water excretion, and the combination of conivaptan with ACE inhibition was the only treatment to reduce blood pressure, natriuretic peptide and pulmonary congestion.





